Trans-species rescue of alcohol sedation in Cp1 RNAi flies. a, c Ethanol sedation in flies with repo-Gal4 alone, HMS00725 alone, UAS-GA25021 transgenes alone, and repo-Gal4 with UAS-GA25021. Genotype did not impact ST50 values (panel a: one-way ANOVA, p = 0.4855, n = 8; panel c: one-way ANOVA, p = 0.1683, n = 8). b, d Ethanol sedation in flies with concurrent expression of Cp1 RNAi and GA25021. ST50 values were decreased in flies constitutively expressing the HMS00725 Cp1 RNAi transgene in all glia via repo-Gal4 (blue squares) compared to control flies containing repo-Gal4 alone (black circles). ST50 values in flies that expressed a UAS-GA25021 transgene and HMS00725 Cp1 RNAi in all glia via repo-Gal4 (gray triangles: UAS-GA25021 #1, panel b; UAS-GA25021 #3, panel d) were significantly elevated compared to flies expressing HMS00725 alone (blue squares: UAS-GA25021 #1, panel b; UAS-GA25021 #3, panel d), but were not different than control flies containing repo-Gal4 alone (black circles) (panel b: one-way ANOVA, p < 0.0001, n = 8,; panel d: one-way ANOVA, p = 0.0019; *Bonferroni’s multiple comparison vs. repo-Gal4;HMS00725 flies, p < 0.05). e–j Whole-mount brain images immunolabeled for Cp1. Whole-brain fluorescence was reduced in flies constitutively expressing the HMS00725 Cp1 RNAi transgene in all glia via repo-Gal4 (f) compared to brains that contained repo-Gal4 alone (e). Compared to brains that contained repo-Gal4 alone (e), whole-brain fluorescence was increased when a UAS-GA25021 transgene was expressed in all glia via repo-Gal4 (UAS-GA25021 #1, panel g; UAS-GA25021 #3, panel i). Compared to brains that expressed the HMS00725 Cp1 RNAi transgene in all glia via repo-Gal4 (f), whole-brain fluorescence was increased when a UAS-GA25021 transgene was expressed with the HMS00725 Cp1 RNAi transgene in all glia via repo-Gal4 (UAS-GA25021 #1, panel h; UAS-GA25021 #3, panel j). Representative images from middle sections of adult brains, ×10 (Anti-Cp1 1:250; Alexa 568 1:1000)